Ordaõs Looks To Unlock The Therapeutic Promise Of Mini-Proteins
Executive Summary
Emerging Company Profile: Mini-proteins offer some of the capabilities of small molecules and antibodies with fewer limitations, Ordaõs claims. The biotech wants to lead a paradigm shift from discovery to design.